Relative Bioavailability of BI 201335 Capsule Versus Three Different Oral Solutions
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The objective of the current study is to investigate the relative bioavailability of two
different doses of BI 201335, administered as soft gelatine capsule in comparison to the
equivalent doses of three different oral solution per dose of BI 201335.